Elisa Giannoni
 Associate Professor
                            Department of Biomedical, Experimental and Clinical Sciences                                                        
University of Florence
                                                        Italy
                        
Biography
Elisa Giannoni is Associate Professor in Biochemistry at the Human Health Medical School of the University of Florence and works at the Dept. of Experimental and Clinical Biomedical Sciences of Florence. 1973- Born in December 1st 1973 in Empoli (FI). 1997- Degree in Biological Sciences at the University of Florence. 1997-1998- Post-degree assistant at the Department of Biochemistry of the University of Florence. 2002- PhD in Biochemistry. 2002-2005- Fellowship at the Department of Biochemistry of the University of Florence. 2005- Assistant Professor in Methods and Didactics of Motor Activities at the Faculty of Medicine and Surgery at the University of Florence. 2013- Assistant Professor in Biochemistry at the Human Health Medical School of the University of Florence.
Research Interest
Biochemistry
Publications
- 
                            Bacci, M; Giannoni, E; Fearns, A; Ribas, R; Gao, Q; Taddei, Ml; Pintus, G; Dowsett, M; Isacke, Cm; Martin, La; Chiarugi, P; Morandi, A (2016). miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors.. CANCER RESEARCH, vol. 76(6), pp. 1615-1626, ISSN:0008-5472 
- 
                            Ippolito, Luigi; Marini, Alberto; Cavallini, Lorenzo; Morandi, Andrea; Pietrovito, Laura; Pintus, Gianfranco; Giannoni, Elisa; Schrader, Thomas; Puhr, Martin; Chiarugi, Paola; Taddei, Maria Letizia (2016). Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.. ONCOTARGET, vol. 7, pp. 61890-61904, ISSN:1949-2553 
- 
                            Morandi, Andrea; Taddei, Maria Letizia; Chiarugi, Paola; Giannoni, Elisa (2017). Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors. FRONTIERS IN ONCOLOGY, vol. 7:40, pp. 1-19, ISSN:2234-943X 

